WeRide Inc. — Board/Management Information 2009

Hong Kong Exchange and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement. This announcement is for information purposes only and does not constitute an invitation or offer to acquire, purchase or subscribe for any securities.

Resignation of director and

CHANGE OF CHAIRMAN

The board of directors (the “Board”) of Far East Pharmaceutical Technology Company Limited (the “Company”) announces that Mr. Tai Kai Hing (“Mr. Tai”) has resigned as an executive director, the chairman of the Board and the chairman of the remuneration committee of the Company all with effect from 9 February 2009.

Mr. Tai confirms that he does not have any disagreement with the Board and that there is nothing relating to his resignation that needs to be brought to the attention of the shareholders of the Company.

The Board would like to take this opportunity to thank Mr. Tai for his valuable contribution to the Company during his tenure of office.

The Board also announces that Mr. Shen Xiao-dong (“Mr. Shen”), being an executive director of the Company, has been appointed as the chairman of the Board and the chairman of the remuneration committee of the Company with effect from 9 February 2009.

Mr. Shen, aged 40, graduated from 華東師範大學 (East China Normal University) with a Bachelor of Science and a Master of Philosophy. Mr. Shen has worked over 10 years as head of investment for several investment and biological technology companies in the People’s Republic of China (the “PRC”). Mr. Shen has the extensive experience in financing, investment, project valuation and risk management in the PRC capital market.

Hong Kong, 9 February 2009

As at the date of this announcement, the Board comprises two executive directors, namely Mr. Shen Xiao-dong and Mr. Jiang Jian, and three independent non-executive directors, namely Mr. Chiu Koon Shou, Victor, Mr. Chung Wai Man and Dr. Leung Wai Cheung.

The directors of the Company jointly and severally accept full responsibility for the accuracy of the information contained in this announcement, and confirm, having made all reasonable inquiries, that to the best of their knowledge, opinions expressed in this announcement, have been arrived at after due and careful consideration, and there are no other facts not contained in this announcement, the omission of which would make any statement in this announcement misleading.

Please also refer to the published version of this announcement on the Company’s website: http://www.feptcl-399.info/.